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Edited by Laszlo NagyAbstract Proton Nuclear Magnetic Resonance spectroscopy
and Gas Chromatography Mass Spectrometry based metabolo-
mics has been used in conjunction with multivariate statistics
to examine the metabolic changes in Caenorhabditis elegans fol-
lowing the deletion of nuclear hormone receptor-49 (nhr-49).
Deletion of the receptor produced profound changes in fatty acid
metabolism, in particular an increase in the ratio of unsaturated
to saturated fatty acids, a decrease in the concentration of glu-
cose and increases in lactate and alanine. Given the proposed
functional similarity between nhr-49 and the mammalian perox-
isome proliferator-activated receptors (PPARs) these changes
were compared with the metabolome of the PPAR-a null mouse.
The metabolomic approach demonstrated a number of similari-
ties including the regulation of lipid synthesis, b-oxidation of
fatty acids and changes in glycolysis/gluconeogenesis.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The nematode worm Caenorhabditis elegans is an ideal tool
for functional genomics. It has been characterised in great de-
tail in terms of its development, morphology and physiology at
the cellular level and its genome has been completely se-
quenced [1]. A powerful genetic toolset for C. elegans is avail-
able and a large collection of mutants are available. In
addition, C. elegans is one of the few animals for which
high-throughput in vivo RNA interference (RNAi) screening
has been established [2]. Many of the genes involved in human
disease, including those involved in diabetes and obesity, have
homologues in C. elegans and their study has made a large
contribution to our current understanding of the gene path-
ways involved in human disease.
In functional genomic studies of yeast, Raamsdonk and col-
leagues suggested an approach based on metabolomics to re-
veal the phenotypes of silent mutations [3]. This has been
further demonstrated in the excreted metabolites produced*Corresponding author. Fax: +44 0 1223 333 345.
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doi:10.1016/j.febslet.2008.04.020by yeast (metabolic footprinting; [4]). In a similar manner,
metabolomics has been shown to be highly discriminatory
for a variety of mutants in diﬀerent organisms including Ara-
bidopsis [5] and mice [6].
In this study we have examined the metabolome of C. ele-
gans using a combination of 1H Nuclear Magnetic Resonance
(NMR) spectroscopy to examine aqueous soluble metabolites
and Gas Chromatography Mass Spectrometry (GC–MS) to
examine the total fatty acid composition. These tools have
been used in conjunction with multivariate statistics to exam-
ine the role of nhr-49. Whilst this nuclear hormone receptor
has signiﬁcant homology with hepatocyte nuclear factor 4
(HNF4) in mammals, Van Gilst and colleagues have proposed
the function is closer to the mammalian peroxisome prolifera-
tor-activated receptors (PPARs) [7,8]. The metabolic pheno-
type of C. elegans nhr-49 mutants has therefore been
compared with the metabolic changes in the PPAR-a null
mouse in order to demonstrate the translational potential of
metabolomics-based functional genomics.2. Methods
2.1. Nematode methods
C. elegans was grown using standard conditions at 20 C on plates
seeded with Escherichia coli strain OP50 [9]. The wild-type strain was
var. Bristol N2 [10]. The nhr-49 mutant strain used was VC870
(nhr-49(gk405)), which was generated by the C. elegans knockout con-
sortium [11] and distributed by the Caenorhabditis Genetics Center,
University of Minnesota, Twin Cities, MN. For each experiment
approximately 2000 mixed-stage animals were harvested and nine re-
peats were made. The animals were washed twice in double distilled
H2O, centrifuged (2000 rpm, 20 min) and the worm pellets were stored
at 80 C until extraction.2.2. Mouse husbandry
Tissues from SVEV/129 mice, and PPAR-a null mice (n = 5; 5
months of age) were obtained from stable colonies at the University
of Oxford. The UK Home Oﬃce approved all procedures. Mice were
fed standard laboratory chow ad libitum prior to death (Special Diet
Services, Essex, UK). Animals were killed by terminal anaesthesia
and livers were collected within 30 s. All livers were stored at 80 C
until extraction.2.3. Metabolite extraction
Metabolites from mouse liver tissue or whole nematodes were ex-
tracted using a methanol–chloroform extraction procedure. Frozen tis-
sue (100 mg) was pulverised with dry ice, 600 ll of a methanol–
chloroform mix (2:1 v:v) was added and samples were sonicated for
15 min. Two hundred microliters each of chloroform and water wereblished by Elsevier B.V. All rights reserved.
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overnight in an evacuated centrifuge and the lipid fraction was dried
overnight under nitrogen.
2.4. High resolution 1H NMR spectroscopy of aqueous fraction
The dried extracts were rehydrated in 600 ll D2O, buﬀered in 0.24 M
sodium phosphate (pH 7.0) containing 1 mM (sodium-3-(tri-methylsi-
lyl)-2,2,3,3-tetradeuteriopropionate (TSP) (Cambridge Isotope Labo-
ratories MA, USA) as an internal standard. The samples were
analysed using an AVANCE II+ NMR spectrometer operating at
500.13 MHz for the 1H frequency (Bruker, Germany) using a 5 mm
TXI probe. Spectra were collected using a solvent suppression pulse se-
quence based on a one-dimensional NOESY pulse sequence to saturate
the residual 1H water signal (relaxation delay = 2 s, t1 = 3 ls, mixing
time = 150 ms, solvent presaturation applied during the relaxation
time and the mixing time). One hundred and twenty-eight transients
were collected into 16 K data points over a spectral width of 12 ppm
at 27 C. In addition, representative samples of nematodes were also
examined by two-dimensional spectroscopy, including COSY (COrre-
lation SpectroscopY) and HSQC (Heteronuclear Single Quantum
Coherence) spectroscopy [12], in conjunction with reference to previ-
ous literature and databases ([13,14]; Madison Metabolomics Consor-
tium Database, http://mmcd.nmrfam.wisc.edu/index.html and the
Chenomx spectral database contained in Chenomix NMR Suite 5.0
(Chenomx, Alberta, Canada)).
2.5. GC–MS of lipid fraction
Lipids were dissolved in 0.25 ml of chloroform/methanol (1:1 v/v).
100 ll BF3/methanol (Sigma-Aldrich) was added and the vials were
incubated at 80 C for 90 min. 0.3 ml H2O and 0.6 ml hexane was
added and each vial vortex mixed. The organic layer was evaporated
to dryness before reconstitution in 200 ll hexane for analysis.
The derivatised organic metabolites were injected onto a ZB-WAX
column (30 m · 0.25 mm ID · 0.25 lm df; 100% polyethylene glycol).
The initial column temperature was 60 C and was held for 2 min. This
was increased by 15 C min1 to 150 C then increased at a rate of
4 C min1 to 230 C. The column eluent was introduced into a Trace
DSQ quadrupole mass spectrometer (Thermo Electron) (transfer line
temperature = 240 C, ion source temperature = 250 C, electron bea-
m = 70 eV). The detector was turned on after 240 s and data was col-
lected in full scan mode using three scans s1 across a mass range of
50–650 m/z.
2.6. Multivariate statistical analysis
NMR spectra were processed using ACD one-dimensional NMR
processor (vers. 8, ACD, Toronto, Canada). Free induction decays
were Fourier transformed following multiplication by a line broaden-
ing of 1 Hz, and referenced to TSP at 0.0 ppm. Spectra were phased
and baseline corrected manually. Each spectrum was integrated using
0.04 ppm integral regions between 0.5 and 4.5, and 5.1–10.0 ppm. Each
spectral region was normalised to a total integral value of 10000. In
addition the Chenomx software was used to peak ﬁt individual metab-
olites, and a dataset was produced consisting of these ﬁtted resonances.
GC–MS Chromatograms were analysed using Xcalibur, version 2.0
(Thermo Fisher), integrating each peak individually. Each integrated
peak was normalised so that the total sum of peaks was set to
10000. Deconvolution of overlapping peaks was achieved by traces
of single ions. Mass spectra were assigned using the NIST database
of mass spectra and standard compound analysis.
Datasets were imported into SIMCA-P 11.0 (Umetrics, Umea˚, Swe-
den) for processing using principal components analysis (PCA) and
partial least squares-discriminate analysis (PLS-DA; a regression
extension of PCA used for supervised classiﬁcation). GC–MS data
was scaled to unit variance by dividing each variable by 1/(Sk) where
Sk is the standard deviation of the variable.
1H NMR spectroscopy
data was Pareto scaled, in which each variable was centred and multi-
plied by 1/(Sk)
1/2. Identiﬁcation of major metabolic perturbations with-
in the pattern recognition models was achieved by analysis of
corresponding loadings plots, with metabolites selected which are con-
sidered to have a signiﬁcant contribution to that PC (p < 0.05 follow-
ing a jack kniﬁng routine). Additionally, R2 and Q2 were used as
measures for the robustness of a pattern recognition model. R2 is the
fraction of variance explained by a component, and cross validation
of R2 gives Q2 which reveals the fraction of the total variation pre-dicted by a component. In addition a leave-one-out analysis was per-
formed on each C. elegans dataset to examine how well class
membership was predicted.3. Results
Fig. 1a shows a high resolution 1H NMR spectrum acquired
in 14 min of the aqueous metabolites extracted from C. ele-
gans. Using the library and peak ﬁtting routine within the Che-
nomx NMR Suite 5.0 software package, a total of 55
metabolites were identiﬁed and quantiﬁed, and conﬁrmed by
the use of two-dimensional NMR spectroscopy (Fig. 1b and
c) and GC–MS [Supplementary Table 1 and Fig. 1].
Using a bucketing routine to integrate the NMR spectra and
applying PLS-DA to the resultant dataset, classiﬁcation into
wild-type and nhr-49 mutants was achieved (Fig. 2a; Supple-
mentary Fig. 2a). Using a leave one out analysis of the data
set all samples except one were accurately predicted to belong
to the correct group. On inspection this sample belonged to a
spectrum with a low signal to noise ratio. Examination of the
loadings plots showed that the metabolites which were respon-
sible for this classiﬁcation were increases in lactate (d 1.30–
1.34, signifying the bucket represented in the loadings plot),
alanine (d 1.46–1.50), leucine (d 1.62–1.66) and decreases in ly-
sine (d 2.98–3.06), glucose (d 3.26–3.34; d 3.50–3.62), malonate
(d 3.10–3.14) and aspartate (d 2.70–2.74) in the mutant worms.
Examination of the total fatty acid complement of C. elegans
demonstrated that a total of 42 peaks were detected in the
chromatogram, with 31 of these being identiﬁed through a
combination of the NIST library and retention time matching
of known standards [Supplementary Table 2 and Supplemen-
tary Fig. 1]. Applying PLS-DA to the integrated peaks of the
chromatograms the two groups were separated across 2 PLS-
DA components (Fig. 2b; Supplementary Fig. 2b). Using a
leave-one-out analysis the class membership of all samples
were correctly predicted, although two samples were identiﬁed
as being outliers to the model according to the distance to
model criteria. These samples contained high concentrations
of palmitoleidic acid which is found in high concentrations
within E. coli, and may relate to a higher proportion of
E. coli to C. elegans in the agar lawn at sampling. Examining
the loadings plots of the PLS-DAs for the fatty acid data
set, the metabolites increased in the mutant nematodes were
a-linolenic acid, arachidonic acid, non-adecanoic acid, di-
homo-c-linolenic acid (8,11,14-eicosatrienoic acid), heptadece-
noic acid, c-linolenic acid and docosanoic acid and there was a
decrease in a branched chain form of palmitate. Using a Coo-
mans plot analysis the lipid proﬁles correctly predicted geno-
type for all samples (Supplementary Fig. 2c).
Metabolomic analysis of liver from the 5-month PPAR-a
null mouse revealed a number of changes similar to those ob-
served in the nhr-49 mutant C. elegans strain. 1H NMR spec-
troscopy of the aqueous soluble metabolites in conjunction
with PLS-DA showed the PPAR-a null samples could be dif-
ferentiated from age matched controls through an increase in
lactate (d 1.30–1.34), citrate (d 2.54–2.58) and glutamate (d
2.10–2.18, 2.34–2.38) and a decrease in glucose concentration
(d 3.38–3.42), (d 3.72–3.76), (d 3.90–3.94) and (d 5.20–5.24)
and taurine (d 3.42–3.46; 3.26–3.30) (R2 = 0.88, Q2 = 0.47)
(Fig. 2c). Similarly, PLS-DA of the fatty acid composition, fol-
lowing analysis by GC–MS, was able to distinguish PPAR-a
Fig. 1. (a) Annotated 1H NMR spectrum showing aqueous soluble metabolites extracted from C. elegans. Assignments were conﬁrmed through the
use of COSY (b) and HSQC (c) spectra. Key: 1. ANP, 2. formate, 3. GTP, 4. hypoxanthine, 5. nicotinamide, 6. indoxyl sulphate, 7. 4-
Hydroxyphenylacetic acid, 8. phenylalanine, 9. phenylacetylglycine, 10. lactate, 11 alanine, 12. inosine, 13. fumarate, 14. acetate, 15. succinate, 16,
malate, 17. TMAO, 18. choline, 19 lysine, 20. leucine, 21. iso-leucine, 22. valine, 23. threonine, 24. beta-alanine, 25. glutamine, 26. glutamate, 27.
histidine, 28. tyrosine, 29. phosphocholine, 30. aspartate, 31. alpha-ketoglutarate, 32. methionine, 33. myo-inositol, 34. glycine, 35. melonate, 36.
glucose-6-phosphate, 37. glucose, 38. fructose, 39. methanol, 40. serine, 41. proline, 42. betaine. In addition there are numerous sugar and amino acid
resonances between 3.3 and 4.0 ppm.
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arachidonic acid, linoleic acid, eicosanoic acid, lauric acid, and
di-homo-c-linolenic acid (8,11,14-eicosatrienoic acid), and a
decrease in concentration of palmitic acid, and a branched
chain 16:0 fatty acid (R2 = 0.81, Q2 = 0.25; Fig. 2d).
To compare directly the mutants, PLS-DA models were con-
structed of the aqueous (NMR spectroscopy) and lipid phase
(GC–MS) datasets. No model could be built that successfully
separated mutants from wild-type for the combined NHR-49
and PPAR-a aqueous dataset, with this dataset being domi-
nated by the diﬀerences between species. However, a compar-
ison of the loadings for the diﬀerent PLS-DA plots that
distinguished mutant from wild-type for the aqueous extracts
demonstrated some marked similarities, and in particular that
both mutants had a decreased concentration of glucose and in-
creased concentration of lactate (Fig. 2e). Using PLS-DA to
analyse all the lipid extracts, separation was detected in PLS-DA component 1 according to species (R2(X) = 64%;
R2(Y) = 32%; Q2 = 27%) and according to mutant/wild-type
status in PLS-DA component 2 (R2(X) = 17%; R2(Y) = 15%;
Q2 = 11%) (Fig. 2f). This separation was caused by a decrease
in oleate and increases in arachidonic acid, eicosanoic acid and
di-homo-c-linolenic acid in the mutants (Fig. 2g).4. Discussion
In this study we have demonstrated the versatility of a com-
bined high resolution 1H NMR spectroscopy and GC–MS
based proﬁling approach to study metabolic changes in C. ele-
gans. The approach detected and quantiﬁed 100 metabolites
of which 86 were identiﬁed. Both approaches are rapid and
cheap on a per sample basis, indicating they could be used
as a rapid screening tool of C. elegans mutants. The metabolic
Fig. 2. Score plots showing the diﬀerentiation of nhr-49 () and N2 control C. elegans nematodes (n) following (a) PLS-DA of the aqueous soluble
metabolites by 1H NMR spectroscopy (R2(X) = 38%; R2(Y) = 76%; Q2 = 54%) and (b) PLS-DA analysis of the total lipid compliment by GC–MS
following methyl esteriﬁcation (R2(X) = 54%, R2(Y) = 92%; Q2 = 76%). (c) PLS-DA score plots showing the diﬀerentiation of PPAR-a null tissue (s)
and control tissue (n) following analysis of the aqueous soluble metabolites by 1H NMR spectroscopy, and (d) following PLS-DA analysis of the
total lipid composition by GC–MS following methyl esteriﬁcation. (e) A comparison of the loadings for PLS-DA 1 from the scores plots displayed in
(a) and (c) demonstrating a number of similarities between the two PLS-DA plots. Positive values indicate an increase in the mutant (black bars are
mice, white bars are C. elegans). The error bars were derived from jack kniﬁng to determine the leverage each variable had on the PLS-DA
component. Where no bar is shown for a metabolite this metabolite did not change signiﬁcantly in concentration as judged by the jack kniﬁng
routine. (f) PLS-DA plot comparing the total lipid composition for both mutant models. Key: nhr-49 (n) and N2 control C. elegans nematodes ();
PPAR-a null tissue (¤) and control mouse tissue (D) (g) coeﬃcients of the major components contributing to PLS-DA 2 of the scores plot in (f) which
separated mutants from wild-types. The error bars were derived from jack kniﬁng to determine the leverage each variable had on the PLS-DA
component. A positive value indicates a decrease in mutant animals. Only variables where the weightings were signiﬁcantly diﬀerent from zero as
determined by the jack-kniﬁng procedure are included.
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the PPAR-a null mouse, demonstrating the metabolic similar-
ity of the consequences for the loss of these genes in the two
diﬀerent species.
Previous studies looking at metabolism in the PPAR-a null
mouse during fasting have described a signiﬁcant reduction
in fatty acid metabolism via b oxidation which has been attrib-
uted to a loss of regulation of genes that encode enzymes crit-
ical to this pathway [15], while we have previously detected a
milder phenotype in fed animals [16]. In this study, we ob-
served an increase in linoleic and di-homo-c-linolenic acid
(8,11,14-eicosatrienoic acid) in PPAR-a null livers and similar
changes were observed in the nhr-49 mutant nematodes with
an increases in concentration of di-homo-c-linolenic acid
(8,11,14-eicosatrienoic acid), a-linolenic and c-linolenic acid.
This was further demonstrated by a combined analysis suggest-
ing that nhr-49 and PPAR-a have similar roles in the regulation
of metabolism. These fatty acids are precursors for arachidonic
acid, with the expression of the desaturases and elongase in-
volved in this pathway being under PPAR-a control in mice
and nhr-49 control in C. elegans. These changes are also in
keeping with the Q-PCR analysis performed by Van Gilst
et al. [7] who detected decreased expression of fat-5, fat-6 and
fat-7 (three D9-desaturases) transcripts involved in desatura-
tion/elongation and acyl CoA synthetase (acs-2) and trifunc-
tional enzyme (ech-1). Comparing these to known PPAR-a
targets in mammals (e.g. http://www.genome.jp/dbget-bin/
get_pathway?org_name=mmu&mapno=03320), both recep-
tors target D9-desaturases and acyl-CoA synthetases.
One notable diﬀerence between our present study and that of
Van Gilst et al. [7] examining the nhr-49 mutant was that we
detected no change in stearate, despite a marked increase being
detected in the previous study. Similar increases in stearate
have been detected in fat-7 (F10D2.9; homologous with mam-
malian stearoyl-CoA desaturase and induced by nhr-49) and
nhr-80 mutants [7,17]. However, stearate also increases during
fasting and the expression of fat-7 varies markedly during
development and fasting, suggesting that the concentration
of stearate may be highly variable according to the physiolog-
ical and developmental state of the nematodes, particularly in
a colony of mixed stage animals. Despite, no alteration in the
concentration of stearate being detected, the concentration of
oleate was found to be signiﬁcantly reduced in the mutant
nematodes (Fig. 2g), a ﬁnding consistent with a reduction in
the expression of D9-desaturase. Van Gilst et al. [7] reported
that the expression of D9-desaturase (which converts stearate
to monounsaturated oleate) was signiﬁcantly decreased by
nhr-49 deletion. Oleate was also signiﬁcantly reduced in the
PPAR-a null livers (Fig. 2g), thus providing further evidence
that NHR-49 and mammalian PPAR-a may have similar reg-
ulatory eﬀects on the pathways of lipid metabolism.
In the nhr-49 nematodes the perturbation in fat metabolism
was accompanied by a decrease in glucose and an increase in
lactate and alanine, indicative of an increase in the relative ra-
tio of glycolysis to gluconeogenesis. Similar changes were also
detected in the liver tissue of PPAR-a knock out mice in this
study and in younger animals [16]. In mice, PPAR-a is known
to control pyruvate dehydrogenase kinase 4 (PDK4) activity,
and this can limit ﬂux through the Krebs cycle by inhibiting
pyruvate dehydrogenase [18]. Loss of PPAR-a prevents
PDK4 expression, and this may lead to an active form of pyru-
vate dehydrogenase in the liver causing increased glucose util-isation. A similar interaction may exist between nhr-49 and
PDK in nematodes. Another plausible hypothesis is that there
may be reduced ﬂux through the glycolylate pathway arising
from a decrease in precursor fatty acid b oxidation products,
in particular acetyl Co-A, decreasing glucose synthesis.
In conclusion, our combined metabolomic approach sug-
gests that nhr-49 has a role in regulating lipid synthesis, b-oxi-
dation of fatty acids, glycolysis and gluconeogenesis in a
similar manner to the role of PPAR-a in the mouse liver.
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